ProPhase Labs Statistics

Total Valuation

ProPhase Labs has a market cap or net worth of $13.92 million. The enterprise value is $27.84 million.

Market Cap	13.92M
Enterprise Value	27.84M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ProPhase Labs has 41.54 million shares outstanding. The number of shares has increased by 41.23% in one year.

Current Share Class	41.54M
Shares Outstanding	41.54M
Shares Change (YoY)	+41.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.02%
Owned by Institutions (%)	12.22%
Float	38.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.42
Forward PS	0.72
PB Ratio	0.92
P/TBV Ratio	17.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.93.

Current Ratio	1.03
Quick Ratio	0.84
Debt / Equity	0.93
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-10.05

Financial Efficiency

Return on equity (ROE) is -162.30% and return on invested capital (ROIC) is -44.51%.

Return on Equity (ROE)	-162.30%
Return on Assets (ROA)	-30.92%
Return on Invested Capital (ROIC)	-44.51%
Return on Capital Employed (ROCE)	-133.01%
Revenue Per Employee	$60,885
Profits Per Employee	-$449,302
Employee Count	96
Asset Turnover	0.08
Inventory Turnover	2.21

Taxes

In the past 12 months, ProPhase Labs has paid $9.76 million in taxes.

Income Tax	9.76M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.37% in the last 52 weeks. The beta is -0.42, so ProPhase Labs's price volatility has been lower than the market average.

Beta (5Y)	-0.42
52-Week Price Change	-92.37%
50-Day Moving Average	0.33
200-Day Moving Average	0.92
Relative Strength Index (RSI)	46.97
Average Volume (20 Days)	4,055,695

Short Selling Information

The latest short interest is 323,099, so 0.78% of the outstanding shares have been sold short.

Short Interest	323,099
Short Previous Month	230,559
Short % of Shares Out	0.78%
Short % of Float	0.85%
Short Ratio (days to cover)	0.17

Income Statement

In the last 12 months, ProPhase Labs had revenue of $5.85 million and -$43.13 million in losses. Loss per share was -$1.74.

Revenue	5.85M
Gross Profit	436,000
Operating Income	-34.66M
Pretax Income	-32.20M
Net Income	-43.13M
EBITDA	-28.60M
EBIT	-34.66M
Loss Per Share	-$1.74

Full Income Statement

Balance Sheet

The company has $88,000 in cash and $14.01 million in debt, giving a net cash position of -$13.92 million or -$0.34 per share.

Cash & Cash Equivalents	88,000
Total Debt	14.01M
Net Cash	-13.92M
Net Cash Per Share	-$0.34
Equity (Book Value)	15.12M
Book Value Per Share	0.36
Working Capital	718,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.78 million and capital expenditures -$39,000, giving a free cash flow of -$15.82 million.

Operating Cash Flow	-15.78M
Capital Expenditures	-39,000
Free Cash Flow	-15.82M
FCF Per Share	-$0.38

Full Cash Flow Statement

Margins

Gross Margin	7.46%
Operating Margin	-593.00%
Pretax Margin	-665.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProPhase Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.23%
Shareholder Yield	-41.23%
Earnings Yield	-309.85%
FCF Yield	-113.63%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 23, 1997. It was a forward split with a ratio of 2:1.

Last Split Date	Jan 23, 1997
Split Type	Forward
Split Ratio	2:1

Scores

ProPhase Labs has an Altman Z-Score of -2.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.84
Piotroski F-Score	2